M. Bartucci

发表

The miR-15a–miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities

Mauro Biffoni, Ruggero De Maria, Cesare Peschle, 2008, Nature Medicine.

“MetasTAZation” and beyond

M. Bartucci, 2015, Oncoscience.

DNA Damage Repair Pathways in Cancer Stem Cells

M. Bartucci, R. De Maria, M. Maugeri-Saccà, 2012, Molecular Cancer Therapeutics.

Estrogen receptor-α regulates the degradation of insulin receptor substrates 1 and 2 in breast cancer cells

E. Surmacz, C. Morelli, C. Garofalo, 2003, Oncogene.

DNA Damage and Repair Biomarkers in Cervical Cancer Patients Treated with Neoadjuvant Chemotherapy: An Exploratory Analysis

L. Mariani, G. Sanguineti, I. Vitale, 2016, PloS one.

Erythropoietin activates cell survival pathways in breast cancer stem-like cells to protect them from chemotherapy.

M. Todaro, G. Stassi, M. Bartucci, 2013, Cancer research.

IGF-I Receptor-induced Cell-Cell Adhesion of MCF-7 Breast Cancer Cells Requires the Expression of Junction Protein ZO-1*

S. Andò, E. Surmacz, C. Morelli, 2001, The Journal of Biological Chemistry.

Corrigendum: Personalized Medicine Approaches in Prostate Cancer Employing Patient Derived 3D Organoids and Humanized Mice

M. Yarmush, M. Bartucci, A. Ferrari, 2016, Front. Cell Dev. Biol..

Synthesis and Characterization of Novel BMI1 Inhibitors Targeting Cellular Self-Renewal in Hepatocellular Carcinoma

John Gilleran, D. Augeri, S. D. Kimball, 2017, Targeted Oncology.

Rescued by Stem Cell Factor Selective Death of Megakaryocyte Progenitors and Can Be Chemotherapy-Induced Thrombocytopenia Derives from the

R. Maria, C. Peschle, M. Bartucci, 2007 .

SHC–α5β1 Integrin Interactions Regulate Breast Cancer Cell Adhesion and Motility

S. Andò, E. Surmacz, D. Sisci, 1999 .

Selective GPER activation decreases proliferation and activates apoptosis in tumor Leydig cells

S. Andò, I. Casaburi, M. Bartucci, 2013, Cell Death and Disease.

Utility of Glioblastoma Patient-Derived Orthotopic Xenografts in Drug Discovery and Personalized Therapy

M. Bartucci, Sharon R. Pine, H. Sabaawy, 2018, Front. Oncol..

Checkpoint kinase 1 inhibitors for potentiating systemic anticancer therapy.

M. Bartucci, R. De Maria, M. Maugeri-Saccà, 2013, Cancer treatment reviews.

Therapeutic targeting of Chk1 in NSCLC stem cells during chemotherapy

M. Biffoni, E. Pilozzi, C. Rinaldo, 2011, Cell Death and Differentiation.

Inhibition of DNA methylation sensitizes glioblastoma for tumor necrosis factor-related apoptosis-inducing ligand-mediated destruction.

L. Ricci-Vitiani, R. Pallini, G. Stassi, 2005, Cancer research.

Role of estrogen receptor alpha in modulating IGF-I receptor signaling and function in breast cancer.

M. Bartucci, E. Surmacz, 2004, Journal of experimental & clinical cancer research : CR.

Personalized Medicine Approaches in Prostate Cancer Employing Patient Derived 3D Organoids and Humanized Mice

M. Yarmush, M. Bartucci, A. Ferrari, 2016, Front. Cell Dev. Biol..

The Hippo transducers TAZ and YAP in breast cancer: oncogenic activities and clinical implications

I. Vitale, M. Mottolese, M. Bartucci, 2015, Expert Reviews in Molecular Medicine.

BMI-1 Targeting Interferes with Patient-Derived Tumor-Initiating Cell Survival and Tumor Growth in Prostate Cancer

R. DiPaola, J. Bertino, T. Davis, 2016, Clinical Cancer Research.

The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy

R. Maria, M. Mottolese, A. Pagliuca, 2014, Oncotarget.

Chemotherapy-induced thrombocytopenia derives from the selective death of megakaryocyte progenitors and can be rescued by stem cell factor.

Michele Signore, Cesare Peschle, Daniela Martinetti, 2007, Cancer research.

Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.

S. Andò, E. Surmacz, C. Morelli, 2001, Cancer research.

TAZ is required for metastatic activity and chemoresistance of breast cancer stem cells

M. Biffoni, M. Todaro, G. Stassi, 2014, Oncogene.

Estrogen receptor-alpha regulates the degradation of insulin receptor substrates 1 and 2 in breast cancer cells.

E. Surmacz, C. Morelli, C. Garofalo, 2003, Oncogene.

Signal transduction pathways through cytoprotective, apoptotic and hypertrophic stimuli: a comparative study in adult cardiac myocytes

M. Bartucci, A. Lazou, T. Markou, 2011, Cell biochemistry and function.

Obesity hormone leptin induces growth and interferes with the cytotoxic effects of 5-fluorouracil in colorectal tumor stem cells.

L. Ricci-Vitiani, M. Biffoni, E. Surmacz, 2010, Endocrine-related cancer.

Approaching the increasing complexity of non-small cell lung cancer taxonomy.

A. Pagliuca, M. Bartucci, M. Signore, 2014, Current pharmaceutical design.

The Hippo transducer TAZ as a biomarker of pathological complete response in HER2-positive breast cancer patients treated with trastuzumab-based neoadjuvant therapy

R. Maria, M. Mottolese, A. Pagliuca, 2014, Oncotarget.

Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.

S. Andò, E. Surmacz, C. Morelli, 2001, Cancer research.

Prevention of Chemotherapy-Induced Anemia and Thrombocytopenia by Constant Administration of Stem Cell Factor

M. Biffoni, M. Todaro, M. Bartucci, 2011, Clinical Cancer Research.

Cancer Therapy : Preclinical Prevention of Chemotherapy-Induced Anemia and Thrombocytopenia by Constant Administration of Stem Cell Factor

M. Biffoni, M. Todaro, R. Maria, 2011 .

Thrombocytopenia by Constant Administration of Stem Cell Factor Prevention of Chemotherapy-Induced Anemia and Updated

M. Biffoni, M. Todaro, R. Maria, 2011 .

SHC-alpha5beta1 integrin interactions regulate breast cancer cell adhesion and motility.

S. Andò, E. Surmacz, D. Sisci, 1999, Experimental cell research.